English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 12441/13613 (91%)
造訪人次 : 2359430 線上人數 : 125
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
搜尋範圍
全部NHRI
分子與基因醫學研究所
徐欣伶
--期刊論文
--會議論文/會議摘要
查詢小技巧:
您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
進階搜尋
主頁
‧
登入
‧
上傳
‧
說明
‧
關於NHRI
‧
管理
國家衛生研究院 NHRI
>
分子與基因醫學研究所
>
徐欣伶
>
依題名瀏覽
依作者瀏覽
依日期瀏覽
依資料類型瀏覽
社群詳細資訊
簡介:
NA
資料載入中.....
子類別
期刊論文
[
20
/20]
會議論文/會議摘要
[
0
/3]
鄰近社群
劉淦光(2006-2014)
[
23
/23]
劉鴻興
[
9
/9]
喻秋華
[
60
/60]
孫以瀚
[
1
/1]
張仲明
[
30
/31]
張明姿
[
17
/17]
張雅媗
[
10
/10]
徐唯哲
[
8
/8]
施修明
[
35
/39]
松浦功
[
21
/26]
梁啟銘(2006-2007)
[
4
/4]
江運金
[
34
/34]
王紹文
[
15
/15]
王陸海
[
35
/36]
莊志立
[
32
/38]
蔡世峯
[
134
/147]
許惠恒
[
40
/40]
陳俊宏
[
16
/16]
陳怡榮
[
33
/41]
黃秀芬
[
130
/140]
黃麗蓉
[
25
/27]
龔行健
[
61
/63]
其他
[
157
/163]
周玉山(1996-2005)
[
20
/22]
王玲美(2004-2008)
[
4
/4]
葉秀慧(2001-2005)
[
21
/22]
鄭金松(1997-2002)
[
6
/6]
黃奇英(1998-2005)
[
32
/34]
社群統計
近3年內發表的文件:3(13.04%)
含全文筆數:20(86.96%)
文件下載次數統計
下載大於0次:20(100.00%)
下載大於100次:19(95.00%)
檔案下載總次數:13048(0.23%)
最後更新時間: 2025-04-04 01:19
上傳排行
資料載入中.....
下載排行
資料載入中.....
最近上傳
Real-time and regional analysis of ...
Immunotherapeutic IL-6R and targeti...
Sequence-specific targeting of Caen...
Oligo-fucoidan supplementation enha...
Targeting prooxidant MnSOD effect i...
Oligo-fucoidan prevents M2 macropha...
MCT-1/miR-34a/IL-6/IL-6R signaling ...
Oligo-Fucoidan prevents IL-6 and CC...
Oncogenic MCT-1 activation promotes...
Oncogenic MCT-1 activation deregula...
跳至:
(選擇年份)
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(選擇月份)
January
February
March
April
May
June
July
August
September
October
November
December
或輸入年份:
由新到舊排序
由最舊的開始
顯示項目1-23 / 23. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
日期
題名
關聯
2025-02-14
Real-time and regional analysis of the efficacy of anticancer drugs in a patient-derived intratumoral heterogeneous tumor microenvironment
Lab on a Chip. 2025 Feb 14;Article in Press.
2024-03-03
Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer
Theranostics. 2024 Mar 03;14(5):2167-2189.
2023-08-09
Sequence-specific targeting of Caenorhabditis elegans C-Ala to the D-loop of tRNAAla
Journal of Biological Chemistry. 2023 Aug 9;299-302(9):Article number 105149.
2022-09-15
Oligo-fucoidan supplementation enhances the effect of olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice
Journal of Biomedical Science. 2022 Sep 15;29:Article number 70.
2022-01-11
Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress
Cell Death and Disease. 2022 Jan 11;13:Article number 49.
2020-02-12
Oligo-fucoidan prevents M2 macrophage differentiation and HCT116 tumor progression
Cancers. 2020 Feb 12;12(2):Article number 421.
2019-03-18
MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer
Molecular Cancer. 2019 Mar 18(1);18:Article number 42.
2017-09-19
Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression
Scientific Reports. 2017 Sep 19;7:Article number 11864.
2017-04-10
Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression
Oncogenesis. 2017 Apr 10;6(4):Article number e313.
2017-03
Oncogenic MCT-1 activation deregulates oxidative metabolism and promotes lung tumor progression and metastasis
Cancer Research. 2017 Mar;77(Suppl. 6):Meeting Abstract A30.
2015-01
MCT-1 expression promotes neoplastic multinucleation through the Src/p190B signaling activation in triple-negative breast cancer cells
Cancer Research. 2015 Jan;75(1, Suppl.):A69.
2014-10
MCT-1 expression and PTEN deficiency synergistically promote neoplastic multinucleation through the Src/p190B signaling activation
Oncogene. 2014 Oct;33(44):5109-5120.
2012-12
The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities
Molecular Biology of the Cell. 2012 Dec;23:Article number 853.
2012-11
Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity
Oncotarget. 2012 Nov;3(11):1401-1415.
2012-04
Interplay between cell migration and neurite outgrowth eetermines SH2B1Beta-enhanced neurite regeneration of differentiated PC12 cells
PLoS ONE. 2012 Apr;7(4):Article number e34999.
2012-03-01
The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities
Cell Cycle. 2012 Mar 1;11(5):934-952.
2010-12
The antagonism between MCT-1 and p53 affects the tumorigenic outcomes
Molecular Cancer. 2010 Dec;9:Article number 311.
2010-09-27
The adaptor protein SH2B1Beta reduces hydrogen peroxide-induced cell death in PC12 cells and hippocampal neurons
Journal of Molecular Signaling. 2010 Sep;5:Article number 17.
2009-04
Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity
Molecular Cancer Research. 2009 Apr;7(4):536-548.
2007-09-01
MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage
DNA Repair. 2007 Sep;6(9):1319-1332.
2007-09
Apoptotic cleavage of NuMA at the C-terminal end is related to nuclear disruption and death amplification
Journal of Biomedical Science. 2007 Sep;14(5):681-694.
2007-04-19
Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage [Erratum: Oncogene. 2007 Apr;26(16):2283-2289.]
Oncogene. 2007 Apr;26(18):2674-2674.
2005-07
The MCT-1 oncogene product impairs cell cycle checkpoint control and transforms human mammary epithelial cells
Oncogene. 2005 Jul;24(31):4956-4964.
顯示項目1-23 / 23. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
回饋